Revolutionizing AAV manufacturing: innovations in process and capsid development

Casey Nevins, Editor, Cell & Gene Therapy Insights, speaks to Michael DiBiasio-White, Head of Process Development, Affinia Therapeutics, about novel manufacturing approaches for AAV, the delicate ecosystem of upstream and downstream vector production, and the critical importance of plasmid design.

Please enter your email to access content Read now